Literature DB >> 21414458

Exploring eating disorder quality of life and functional gastrointestinal disorders among eating disorder patients.

Suzanne Abraham1, John Kellow.   

Abstract

BACKGROUND: Functional gastrointestinal-like disorders (FGIDs) are prevalent among eating disorder (ED) patients. The aims are to explore the relationship between quality of life related to eating disorders (QOL ED) and FGIDs.
METHODS: Consecutive ED patients, 18-45 years old, completed the Rome II, QOL ED, Irritable Bowel Syndrome QOL (IBS-QOL) and Bowel Symptom Severity Index (BSSI) questionnaires on admission to hospital for treatment of their ED.
RESULTS: Despite the high prevalence of FGIDs (93%), only IBS is clearly correlated with QOL ED scores. The QOL ED subscores significantly related are ED feelings, psychological feelings and effect on daily living. These subscores contain items such as fearing loss of control over your body and feelings, being preoccupied with thoughts of body weight and shape, feeling confused and that eating and exercise have a negative effect on work/study. There were no relationships between QOL ED behavior and individual FGIDs or categories of FGIDs. The QOL ED and IBS-QOL are highly correlated, and there is a positive linear relationship between the QOL ED global and IBS-QOL total and BSSI scores.
CONCLUSION: The presence of IBS (but not other FGIDs) in ED patients is strongly related to eating disordered and psychological feelings. The poorer the QOL ED is, the poorer the IBS-QOL is and the more severe the IBS symptoms are. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21414458     DOI: 10.1016/j.jpsychores.2010.11.009

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  7 in total

1.  Eating Disorders, Autoimmune, and Autoinflammatory Disease.

Authors:  Stephanie Zerwas; Janne Tidselbak Larsen; Liselotte Petersen; Laura M Thornton; Michela Quaranta; Susanne Vinkel Koch; David Pisetsky; Preben Bo Mortensen; Cynthia M Bulik
Journal:  Pediatrics       Date:  2017-11-09       Impact factor: 7.124

2.  Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria.

Authors:  Xiaojie Wang; Georgina M Luscombe; Catherine Boyd; John Kellow; Suzanne Abraham
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 3.  Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.

Authors:  Ashlea Hambleton; Genevieve Pepin; Anvi Le; Danielle Maloney; Stephen Touyz; Sarah Maguire
Journal:  J Eat Disord       Date:  2022-09-05

4.  Diet, Digestion, and the Dietitian: A Survey of Clinicians' Knowledge, Attitudes and Practices to Advance the Treatment of Gastrointestinal Disturbances in Individuals with Anorexia Nervosa.

Authors:  Madeline L West; Caitlin McMaster; Claire L Young; Mohammadreza Mohebbi; Susan Hart; Heidi M Staudacher; Amy Loughman; Anu Ruusunen; Tetyana Rocks
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

5.  Psychosomatic syndromes and anorexia nervosa.

Authors:  Giovanni Abbate-Daga; Nadia Delsedime; Barbara Nicotra; Cristina Giovannone; Enrica Marzola; Federico Amianto; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

Review 6.  A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder.

Authors:  Tamás Ágh; Gábor Kovács; Dylan Supina; Manjiri Pawaskar; Barry K Herman; Zoltán Vokó; David V Sheehan
Journal:  Eat Weight Disord       Date:  2016-03-04       Impact factor: 4.652

7.  Anxiety and Depression Profile Is Associated With Eating Disorders in Patients With Irritable Bowel Syndrome.

Authors:  Chloé Melchior; Charlotte Desprez; Ghassan Riachi; Anne-Marie Leroi; Pierre Déchelotte; Najate Achamrah; Philippe Ducrotté; Marie-Pierre Tavolacci; Guillaume Gourcerol
Journal:  Front Psychiatry       Date:  2020-01-08       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.